Sign in
Taking people in United StatesNo phase

Shockwave treatment of leg artery before heart valve replacement in aortic stenosis

Tests shockwave treatment of calcified leg arteries in people with aortic stenosis having valve replacement.

Key facts

Who runs it
University of Tennessee Graduate School of Medicine
Where
Knoxville, United StatesSee the site
Trial code
Registry title
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
Status
Recruiting
People taking part
100 people, planned
Started
4 Oct 2025
Expected to end
4 Oct 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Shockwave M5 IVL Catheter
  • Modified Seldinger Technique
Record updated
17 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with severe aortic stenosis who are having TAVR, a valve replacement done through a tube in a blood vessel. Their groin artery (common femoral artery) must be heavily calcified.

Age
>18 years of age (minimum age 18 Years).
Sex
All sexes can join.
Disease stage
Severe aortic stenosis (narrowing of the heart's aortic valve), with TAVR planned.
Biomarker or test result
A CT scan must show a > 90-degree arc of calcium (calcium deposits) at the large access site in the groin artery.

Main reasons for not taking part

  • Not able to understand the study procedures
  • Not willing to give consent
  • Memory or thinking problems that affect the ability to give consent
  • Calcium in the femoral artery spread in an unfavorable way

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • >18 years of age
  • Patient with a diagnosis of severe aortic stenosis undergoing TAVR
  • Participants must be able to read and understand study procedures
  • Willing to participate and sign an ICF
  • Patients with > 90-degree arc of calcium at the large bore access site per CT documentation

Who cannot take part

  • Unfavorable calcium distribution of femoral artery
  • Unable to understand study procedures
  • Unwilling to give consent
  • Patients with cognitive impairments that can affect their ability to give consent

Where in United States

  • University of Tennessee Medical CenterKnoxville, United StatesContact: Savannah Allen, MPH Study CoordinatorTaking people

About the trial

What the trial wants to find out

The primary purpose of this study is to observe reduced access site complications in patients with heavily calcified common femoral arteries requiring Transcatheter Aortic Valve Replacement (TAVR)

The 2 groups in the trial

  • Shockwave model (M5) Intravascular Lithotripsy (IVL)Treatment being tested

    Patients will be treated with the Shockwave M5 Intravascular Lithotripsy (IVL) device prior to femoral artery access using the modified Seldinger technique

    Treatment: Shockwave M5 IVL Catheter and Modified Seldinger Technique

  • Standard femoral accessExisting treatment, for comparison

    Patients will receive standard femoral artery access via the modified Seldinger approach without utilizing intravascular lithotripsy in heavily calcified femoral arteries

    Treatment: Modified Seldinger Technique

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
Plain-language title
Shockwave treatment of leg artery before heart valve replacement in aortic stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 August 2026